This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through March 4, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
ICON (ICLR) Gains From New Offerings, Strategic Acquisitions
by Zacks Equity Research
ICON (ICLR) continues to develop its collaboration and delivery models, invest in technology and enhance its project and program management capabilities.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICLR or CRL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICLR vs. CRL: Which Stock Is the Better Value Option?
Recent Price Trend in Icon PLC (ICLR) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Icon PLC (ICLR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
ICON (ICLR) Up 7.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
ICON (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Boosts PFAS Testing Solutions With New Cartridges
by Zacks Equity Research
Waters (WAT) launches Oasis WAX/GCB and GCB/WAX Cartridges for PFAS testing, thus boosting the Waters Operating segment.
Waters (WAT) Boosts Portfolio Strength With Rheo-IS Accessory
by Zacks Equity Research
Waters (WAT) unveils Rheo-IS accessory for its TA Instruments Discovery Hybrid Rheometers, bolstering its overall portfolio.
Icon PLC (ICLR) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Icon PLC (ICLR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Philips (PHG) Expands Sonicare Portfolio With Latest Launch
by Zacks Equity Research
Philips (PHG) adds Philips One for Kids toothbrush into its Sonicare family, boosting its Personal Health business.
ICLR vs. DOCS: Which Stock Is the Better Value Option?
by Zacks Equity Research
ICLR vs. DOCS: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Elevance Health, Cencora and ICON
by Zacks Equity Research
Elevance Health, Cencora and ICON are part of the Zacks Industry Outlook article.
3 Medical Services Stocks to Buy as Industry Trends Improve
by Urmimala Biswas
The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and ICLR are set to gain the most. However, staffing shortages continue to disrupt the growth trend.
Philips (PHG) Aids Personal Health Business With New Campaign
by Zacks Equity Research
Philips (PHG) launches #ShareTheCare brand positioning campaign for Philips Avent, bolstering the Personal Health segment.
ICON (ICLR) Gains From Strategic Deals, New Innovations
by Zacks Equity Research
ICON (ICLR) continues to evolve its collaboration and delivery models, invest in technology, and enhance its project and program management capabilities.
The Zacks Analyst Blog Highlights Apple, Meta Platforms, Intel, Brokers Group and ICON
by Zacks Equity Research
Apple, Meta Platforms, Intel, Brokers Group and ICON are included in this Analyst Blog.
Top Analyst Reports for Apple, Meta Platforms & Intel
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Meta Platforms, Inc. (META) and Intel Corporation (INTC).
Philips (PHG) Aids Diagnostic Imaging With Philips CT 5300
by Zacks Equity Research
Philips (PHG) introduces AI-enabled Philips CT 5300 X-ray CT system, expanding its diagnostic imaging portfolio.
Are You Looking for a Top Momentum Pick? Why Icon PLC (ICLR) is a Great Choice
by Zacks Equity Research
Does Icon PLC (ICLR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Waters (WAT) Boosts LC Solutions Portfolio With New Software
by Zacks Equity Research
Waters (WAT) unveils HPLC CONNECT software, bolstering its liquid chromatography solutions portfolio.
All You Need to Know About Icon PLC (ICLR) Rating Upgrade to Buy
by Zacks Equity Research
Icon PLC (ICLR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Momentum in Icon PLC (ICLR) Should Keep going
by Zacks Equity Research
Icon PLC (ICLR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
ICON (ICLR) Q4 Earnings Surpass Estimates, Margins Expand
by Zacks Equity Research
ICON's (ICLR) solid performance in the fourth quarter reflects continued market leadership across customer segments it serves.
Icon PLC (ICLR) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.58% and 0.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Reasons Growth Investors Will Love Icon PLC (ICLR)
by Zacks Equity Research
Icon PLC (ICLR) could produce exceptional returns because of its solid growth attributes.